R&D Pharma
Manufacturing · Monaco · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Ave Henry Dunant, Monaco, Commune de M...Phone Number
+377 99995244Website
www.rd-pharma.mcRevenue
<$5 MillionIndustry
About R&D Pharma
R&D Pharma Org Chart
Sales Manager, Procurement
Deputy Manager
Is R&D Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when R&D Pharma launches new products
Congratulate Masked Content for being promoted to Masked Content at R&D Pharma
Click to see if R&D Pharma had a recent Job posting/layoffs
Earning: See what the market has to say on R&D Pharma recently announced quarterly report
Funding: Get notified immidiatlly once R&D Pharma has new funding data
Website visits: Recent activity has been detected on your website
R&D Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if R&D Pharma is spiking on competitors!
Check if R&D Pharma has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
R&D Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
R&D Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about R&D Pharma.
R&D Pharma Tech Stack
A closer look at the technologies used by R&D Pharma
R&D Pharma News & Media
Weekend Unlimited Inc. to Acquire R&D Pharma In Jamaica
The Acquisition Will Strengthen the Company’s Holdings with One of Three Tier-3 Jamaican Licenses VANCOUVER, BC / ACCESSWIRE / November 1st, 2018 / Weekend Unlimited Inc. ("Weekend" or the "Company") (CSE: YOLO – FSE: 0OS1) a lifestyle cannabis company, has entered into an arms-length binding letter of intent to add to its brand portfolio with the acquisition of R&D Pharma in Jamaica, securing one of three Tier-3 licenses available in Jamaica. R&D Pharma Highlights include:BELGRAVIA CAPITAL INTERNATIONAL announces LOI with R&D Pharma Corp.
TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce the execution of a letter of intent with R&D Pharma (the “Letter of Intent”), to collaborate in the development of Belgravia’s distributed and decentralized blockchain medical cannabis provenance and quality attestation database.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding R&D Pharma
R&D Pharma, based in Monaco since 2001, specializes in developing solutions for age-related conditions through innovative dermatological technologies. With over 25 years of experience, the company merges the agility of a family-run business with the discipline of large pharmaceutical operations, focusing on targeted medical needs and long-term part... Read More